Search

everythinglearnresearchcommunity

for

Search:↓

More PDCD4 is linked to obesity, insulin problems, and cell death in ovaries for those with polycystic ovary syndrome.

Androgens are important for normal ovarian function and estrogen production, but may not be the main cause of follicle death.

MicroRNAs could be key biomarkers and therapeutic targets for PCOS.

OCT4 helps granulosa cell growth in early-stage follicles, and FSH increases OCT4 through specific pathways.

Aquaporins could be new drug targets for treating polycystic ovary syndrome.

Exosomes from fat-derived stem cells can potentially improve hair growth and could be a new treatment for immune-related hair loss.

Quercetin may help improve symptoms of polycystic ovary syndrome.

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

Heat Shock Proteins are important in the development of Polycystic Ovarian Syndrome and could be targets for new treatments.

Sons of mothers with polycystic ovary syndrome (PCOS) have a higher risk of obesity and insulin resistance, possibly due to certain genes and factors passed down from their mothers.

High levels of male hormones, insulin resistance, and obesity are closely linked and worsen polycystic ovary syndrome, but more research is needed to improve treatments.

Oxidative stress is a key factor in the development of Polycystic Ovary Syndrome, and weight management can improve symptoms.

Oral isotretinoin for severe acne can change hormone levels but does not significantly affect ovarian function.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Women with PCOS have a higher risk of metabolic syndrome and need lifestyle changes and treatment.

Effective PCOS treatments require targeting specific signaling pathways.

Non-coding RNAs could help detect and treat radiation damage.

PCOS causes infertility mainly due to hormonal imbalances, insulin resistance, and chronic inflammation.

Moxibustion may help improve ovarian function by changing androgen levels.

Male pattern hair loss may be linked to the developmental origins of hair follicles.

Estrogens significantly influence hair growth by interacting with receptors in hair follicles and may help regulate the hair growth cycle.

Kelulut Honey can help regulate sex hormone receptors in rats with Polycystic Ovary Syndrome, similar to common medications.

The study found that women with hyperandrogenic PCOS have higher levels of AKT1 and AKT2 proteins in their cells, which may lead to cell dysfunction.

Isotretinoin's effects and side effects, like birth defects and depression, might be due to it causing cell death in various cells.

Connarus semidecandrus Jack extract promotes hair growth and thickness, reduces prostate cancer cell growth, and could potentially be used as a treatment for hair loss.

The Msx2 gene affects feather development in Hungarian white geese and a specific gene variation could indicate feather quality.

DNA methylation changes in women with PCOS could be used as disease markers and suggest new treatment targets.

Melatonin helps regulate hair growth and protects the hair follicle from stress.

SOX9 is essential for the development of various organs and hair follicles.